TrademarkDir
ALLUMERA
LIVE

Serial Number

79078796

Owner

Bellus Medical, LLC

Filing Date

Sep 10, 2009

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ALLUMERA Trademark

Serial Number: 79078796 • Registration: 3916223

ALLUMERA is a trademark filed by Bellus Medical, LLC on September 10, 2009. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Bellus Medical, LLC (7 trademarks)

5005 LBJ Freeway, Ste 370
Dallas, TX 75244

Entity Type: 16

Photocure ASA (33 trademarks)

Oslo N-0275 , NO

Entity Type: 99

Trademark Details

Filing Date

September 10, 2009

Registration Date

February 8, 2011

Published for Opposition

November 23, 2010

Cancellation Date

September 11, 2019

Goods & Services

Surgical and medical apparatus, instruments, articles and materials, all for rejuvenescence of the skin, namely, lamps and illuminators; surgical and medical apparatus, instruments, articles and materials, all for regeneration of the skin, namely, lamps and illuminators

Pharmaceutical preparations for the treatment of dermal conditions; pharmaceutical preparations for the removal of wrinkles; medicated preparations for the treatment of wrinkles; pharmaceutical preparations for regeneration of the skin; medicated preparations for regeneration of the skin

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Apr 6, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Apr 6, 2020 DETH
NEW REPRESENTATIVE AT IB RECEIVED
May 29, 2019 NREP
TOTAL INVALIDATION PROCESSED BY THE IB
Jun 22, 2018 INNT
GENERIC MADRID TRANSACTION SENT TO IB
May 21, 2018 XXSS
GENERIC MADRID TRANSACTION CREATED
May 21, 2018 XXCR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 15, 2018 INTR
CHANGE OF OWNER RECEIVED FROM IB
Oct 13, 2017 CHLD
CANCELLED SECTION 71
Sep 15, 2017 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 8, 2016 REM3
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 16, 2014 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 16, 2014 REAP
NEW REPRESENTATIVE AT IB RECEIVED
Jan 31, 2014 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 22, 2013 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 16, 2013 NREP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 16, 2013 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 16, 2013 REAP
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 19, 2013 FINO
CHANGE OF NAME/ADDRESS REC'D FROM IB
Dec 9, 2012 ADCH
NOTIFICATION PROCESSED BY IB
Nov 30, 2012 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
May 12, 2011 FICS
FINAL DISPOSITION PROCESSED
May 12, 2011 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 8, 2011 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 8, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 23, 2010 NPUB
PUBLISHED FOR OPPOSITION
Nov 23, 2010 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 20, 2010 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2010 CNSA
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 18, 2010 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Oct 15, 2010 CRCV
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2010 CRFA
ASSIGNED TO LIE
Sep 29, 2010 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 22, 2010 TROA
REFUSAL PROCESSED BY IB
May 14, 2010 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 21, 2010 RFCS
REFUSAL PROCESSED BY MPU
Apr 21, 2010 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 21, 2010 RFCR
NON-FINAL ACTION WRITTEN
Apr 20, 2010 CNRT
APPLICATION FILING RECEIPT MAILED
Mar 2, 2010 MAFR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Mar 1, 2010 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 27, 2010 RFCR
NON-FINAL ACTION WRITTEN
Feb 26, 2010 CNRT
ASSIGNED TO EXAMINER
Feb 26, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2010 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 25, 2010 REPR

Related Trademarks

More from this Owner

ACTISINE

ACTISINE

ACTISINE

ACTISINE

BLC

BLC

BLC

BLC

BLC

BLC

PROGEN PRP

PROGEN PRP